newsfilter
← Latest News
GlobeNewswire·

Alumis to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes